EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Efficacy of Xanthan‐Based Chlorhexidine Gel in Peri‐Implant Mucositis Treatment: A Split‐Mouth Randomized Clinical Trial

Jessica Curcio, Jacopo Lanzetti iD, Armando Crupi, Giulia Ambrogio, Umberto Gibello, Andrea Roccuzzo iD, Francesco Pera

Clinical Implant Dentistry and Related Research · 2026-04 · 28 (2)

DOI: 10.1111/cid.70137 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Implant Dentistry and Related Research, online erschienen am 21.03.2026. Verfasst von Jessica Curcio und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Sciences - CIR Dental School, University of Turin, Turin, Italy. Hauptthemen laut MEDLINE: Chlorhexidine, Polysaccharides, Bacterial, Anti-Infective Agents, Local, Dental Implants. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To investigate the potential benefits of Xanthan‐based chlorhexidine gel application in addition to professional mechanical plaque removal (PMPR) in the treatment of peri‐implant mucositis (PM). Material and Methods Subjects diagnosed with PM were consecutively included in this randomized split‐mouth study. All participants received a single session of PMPR using titanium curettes, followed by the application of an air‐polishing glycine powder device. Implants allocated to the Test group were additionally treated with local delivery of Xanthan‐based chlorhexidine gel. Clinical evaluation was performed at T0 (i.e., baseline), at 30 (T1), 90 (T2) and 180 days (T3) after treatment, while treatment success was evaluated at T2 and T3. Change in bleeding on probing (BoP) was considered as primary outcome measure. A logistic multivariate regression model was developed to explore the predictive role of implant and patient‐level variables on primary outcome measure.

Results

Fifty‐nine patients (mean age: 65.4 ± 8.7 years; 54.2% male; 88.1% non‐smokers) and 182 implants completed the study. At T1, only the Test group displayed a significant reduction in BoP ( p < 0.001), PPD ( p = 0.021) and PI ( p = 0.021) compared to T0, while at T2 and T3 clinical improvements were recorded within both groups without any statistically significant difference between groups ( p > 0.05). T2 Treatment success as well as the frequency distribution of complete (BoP = 0) and partial (BoP ≤ 1, ≤ 2, ≤ 3) disease resolution did not significantly differ between groups ( p > 0.05). Multiple regression model revealed that smoking ( p = 0.008), and implant position (i.e., premolar p = 0.009) did significantly affect the primary outcome measure.

Conclusion

The adjunctive use of XanCHX gel did not result in any statistically significant clinical benefit compared to PMPR alone in the treatment of PM up to 6 months, despite the reported clinical positive effects within the first month after treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChlorhexidinePolysaccharides, BacterialAnti-Infective Agents, LocalDental ImplantsPeri-ImplantitisStomatitisHumansMaleFemaleGelsAgedMiddle AgedTreatment Outcome

Stichwörter der Autor:innen

adjunctive treatmentantimicrobialschlorhexidineclinical trialnon‐surgical treatmentperi‐implant mucositis

Substanzen

Chlorhexidinexanthan gumGelsPolysaccharides, BacterialAnti-Infective Agents, LocalDental Implants

Autor:innen und Institutionen

  • Department of Surgical Sciences - CIR Dental School, University of Turin, Turin, Italy.
  • Shanghai Perio-Implant Innovation Center, Institute of Integrated Oral, Craniofacial and Sensory Research, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, Shan…
  • Department of Periodontology, School of Dental Medicine, University of Bern, Bern, Switzerland.

ORCID-Profile: Jacopo Lanzetti, Andrea Roccuzzo

Zitieren

APA

Curcio, J., Lanzetti, J., Crupi, A., Ambrogio, G., Gibello, U., Roccuzzo, A., & Pera, F. (2026). Efficacy of Xanthan‐Based Chlorhexidine Gel in Peri‐Implant Mucositis Treatment: A Split‐Mouth Randomized Clinical Trial. Clinical Implant Dentistry and Related Research, 28(2). https://doi.org/10.1111/cid.70137

Vancouver

Curcio J, Lanzetti J, Crupi A, Ambrogio G, Gibello U, Roccuzzo A, et al. Efficacy of Xanthan‐Based Chlorhexidine Gel in Peri‐Implant Mucositis Treatment: A Split‐Mouth Randomized Clinical Trial. Clinical Implant Dentistry and Related Research. 2026;28(2). doi:10.1111/cid.70137

BibTeX
@article{Curcio2026,
  author = {Curcio, Jessica and Lanzetti, Jacopo and Crupi, Armando and Ambrogio, Giulia and Gibello, Umberto and Roccuzzo, Andrea and Pera, Francesco},
  title = {Efficacy of Xanthan‐Based Chlorhexidine Gel in Peri‐Implant Mucositis Treatment: A Split‐Mouth Randomized Clinical Trial},
  journal = {Clinical Implant Dentistry and Related Research},
  year = {2026},
  volume = {28},
  number = {2},
  doi = {10.1111/cid.70137}
}
Kostenlos starten →